PRGF injections for chronic low back pain
Treatments studied
Part of Bones, joints & muscles, Pain clinical trials.
This trial tests whether injections of a blood-based treatment called PRGF can help people with long-term low back pain caused by worn discs. It is for those who haven't gotten relief from standard treatments like medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had low back pain for at least 3 months that hasn't improved with medication.
- You have a recent MRI (within 6 months) showing disc problems at L4-L5 or L5-S1.
- Your average pain score over the last month is between 6 and 10 out of 10.
- You have not had back surgery or a spinal injection in the last 6 months.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called rhGDF-6 injected into the discs of your spine to help repair them. If you have had low back pain for at least 3 months despite trying other non-surgical treatments, and your MRI shows disc wear or changes, this study may offer a new option.
This trial is testing a treatment approach for people with long-lasting, painful worn-out discs in the lower back (and sometimes leg pain). It looks for people who tried common non-surgical options without enough relief and who may be headed toward a lumbar procedure.
This Phase 3 study tests whether applying a healing material called platelet-rich fibrin (PRF) around the nerve during disc herniation surgery can reduce leftover nerve pain afterward. If you qualify, your team will compare pain intensity between standard care and PRF during the operation.
This trial tests a gel (HYDRAFIL-D) injected into painful discs in your lower back to see if it relieves pain. It's for people whose back pain hasn't improved with other treatments.
This trial tests a new gene therapy called TG-C for people with chronic low back pain caused by degenerative disc disease. The goal is to see if it is safe and tolerable, and it might offer a new treatment option for those who haven't found relief from other therapies.
This study tests if injecting a special cell therapy into a damaged spinal disc can reduce chronic low back pain. It is for people who have had low back pain for at least 6 months and haven't gotten enough relief from other treatments like physical therapy or pain medication.
Hear when a new Diseases [C] - Musculoskeletal Diseases [C05 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.